Newer antiplatelet agents in acute coronary syndromes

This publication has 20 references indexed in Scilit:

• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
  The Lancet, 1997
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients
  Thrombosis Research, 1993
• The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
  British Journal of Clinical Pharmacology, 1993
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
  The Lancet, 1990
• A randomized trial of aspirin and β-carotene among U.S. physicians
  Preventive Medicine, 1985
• Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
  New England Journal of Medicine, 1983